Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ASLAN Pharmaceuticals Lim...

    NASDAQ: ASLN · Real-Time Price · USD
    0.60
    -0.10 (-14.27%)
    At close: Jul 18, 2024, 10:00 PM

    ASLAN Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 12M n/a n/a
    Cost of Revenue
    		 348.5K 331.75K 282.22K
    Gross Profit
    		 11.65M -331.75K -282.22K
    Operating Income
    		 -43.74M -47.88M -33.85M
    Interest Income
    		 404.98K 354.46K 219.00
    Pretax Income
    		 -44.08M -51.28M -31.59M
    Net Income
    		 -44.22M -51.38M -34.71M
    Selling & General & Admin
    		 12.89M 9.88M 11.83M
    Research & Development
    		 42.5M 38M 22.02M
    Other Expenses
    		 -11.13K 356.56K n/a
    Operating Expenses
    		 55.39M 47.88M 33.85M
    Interest Expense
    		 4.33M 3.68M 1.86M
    Selling & Marketing Expenses
    		 -348.5K n/a n/a
    Cost & Expenses
    		 55.74M 47.88M 33.85M
    Income Tax Expense
    		 132.67K 99.22K 3.12M
    Shares Outstanding (Basic)
    		 657.99K 557.96K 521.09K
    Shares Outstanding (Diluted)
    		 657.99K 557.96K 521.09K
    EPS (Basic)
    		 -67.25 -92 -66.5
    EPS (Diluted)
    		 -67.25 -92 -66.5
    EBITDA
    		 -43.39M -47.61M -32.04M
    EBIT
    		 -39.75M -47.61M -29.73M
    Depreciation & Amortization
    		 348.5K 331.75K 282.22K

    Add to Watchlist